Saturday, July 11, 2026

pharma · Hypertension · Breast Neoplasms

Pfizer

Pfizer is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Hypertension, Breast Neoplasms, Complicated Intra-abdominal Infection, Non-Small Cell Lung Cancer, Arthritis, Rheumatoid

New York 10017, US HQ
103,316 Employees
EMA registrant Type
Company details
Clinical program

Maraviroc

Phase 2 · small molecule · Arthritis, Rheumatoid

Maraviroc for Arthritis, Rheumatoid is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

← All Pfizer projects Phase 2 small molecule terminated

Internal code A4001056

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pfizer
Phase
Phase 2
Modality
small_molecule
Indication
Arthritis, Rheumatoid
Status
terminated
Trials
1